Difficulty: Medium
Average Score: 95%
Practice
Which of the following drugs increases cardiac output in congestive heart failure without having any direct myocardial action?
Correct answer
B
Rationale
The correct answer is B) Captopril. Captopril is an angiotensin-converting enzyme (ACE) inhibitor that works by reducing the production of angiotensin II, a potent vasoconstrictor. By dilating blood vessels, captopril reduces afterload on the heart, which leads to reduced cardiac work and increased cardiac output in congestive heart failure (CHF) patients. Captopril does not have direct myocardial actions but rather acts on the systemic vascular resistance to improve cardiac function.
Now, let's analyze why the other options are incorrect:
A) Digoxin is a cardiac glycoside that increases myocardial contractility by inhibiting the sodium-potassium pump. While it can improve symptoms in CHF, it does so by directly acting on the myocardium, unlike captopril.
C) Amrinone is a phosphodiesterase inhibitor that increases contractility and vasodilation, directly affecting the myocardium and blood vessels.
D) Dobutamine is a beta-adrenergic agonist that stimulates cardiac contractility and heart rate, again acting directly on the myocardium.
Educational Context:
Understanding the mechanisms of action of different pharmacological agents in treating congestive heart failure is crucial for healthcare professionals. Knowledge of how each drug affects the cardiovascular system helps in making informed decisions when managing patients with CHF. This question not only tests knowledge of pharmacology but also reinforces the importance of selecting the right medication based on its specific actions to achieve the desired clinical outcomes in CHF patients.
Now, let's analyze why the other options are incorrect:
A) Digoxin is a cardiac glycoside that increases myocardial contractility by inhibiting the sodium-potassium pump. While it can improve symptoms in CHF, it does so by directly acting on the myocardium, unlike captopril.
C) Amrinone is a phosphodiesterase inhibitor that increases contractility and vasodilation, directly affecting the myocardium and blood vessels.
D) Dobutamine is a beta-adrenergic agonist that stimulates cardiac contractility and heart rate, again acting directly on the myocardium.
Educational Context:
Understanding the mechanisms of action of different pharmacological agents in treating congestive heart failure is crucial for healthcare professionals. Knowledge of how each drug affects the cardiovascular system helps in making informed decisions when managing patients with CHF. This question not only tests knowledge of pharmacology but also reinforces the importance of selecting the right medication based on its specific actions to achieve the desired clinical outcomes in CHF patients.